[HTML][HTML] Comprehensive approach to management of multiple sclerosis: addressing invisible symptoms—a narrative review
L Lakin, BE Davis, CC Binns, KM Currie… - Neurology and therapy, 2021 - Springer
Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous
system, leading to neurodegeneration and manifesting as a variety of symptoms. These can …
system, leading to neurodegeneration and manifesting as a variety of symptoms. These can …
[HTML][HTML] Diagnosis and management of progressive multiple sclerosis
G Macaron, D Ontaneda - Biomedicines, 2019 - mdpi.com
Multiple sclerosis is a chronic autoimmune disease of the central nervous system that results
in varying degrees of disability. Progressive multiple sclerosis, characterized by a steady …
in varying degrees of disability. Progressive multiple sclerosis, characterized by a steady …
[HTML][HTML] The Parkinson's disease waiting room of the future: measurements, not magazines
Utilizing technology to precisely quantify Parkinson's disease motor symptoms has evolved
over the past 50 years from single point in time assessments using traditional biomechanical …
over the past 50 years from single point in time assessments using traditional biomechanical …
[HTML][HTML] The Microsoft HoloLens 2 provides accurate measures of gait, turning, and functional mobility in healthy adults
M Miller Koop, AB Rosenfeldt, K Owen, AL Penko… - Sensors, 2022 - mdpi.com
Augmented-reality (AR) headsets, such as the Microsoft HoloLens 2 (HL2), have the
potential to be the next generation of wearable technology as they provide interactive digital …
potential to be the next generation of wearable technology as they provide interactive digital …
Clinical evaluation of siponimod for the treatment of secondary progressive multiple sclerosis: pathophysiology, efficacy, safety, patient acceptability and adherence
S Sabsabi, E Mikhael, G Jalkh, G Macaron… - Patient preference and …, 2022 - Taylor & Francis
Introduction A number of disease-modifying therapies have been approved for use in
relapsing-remitting multiple sclerosis (MS) in the past two decades. However, only few …
relapsing-remitting multiple sclerosis (MS) in the past two decades. However, only few …
[HTML][HTML] Digitizing a therapeutic: development of an augmented reality dual-task training platform for Parkinson's disease
JL Alberts, RD Kaya, K Scelina, L Scelina… - Sensors, 2022 - mdpi.com
Augmented reality (AR) may be a useful tool for the delivery of dual-task training. This
manuscript details the development of the Dual-task Augmented Reality Treatment (DART) …
manuscript details the development of the Dual-task Augmented Reality Treatment (DART) …
Expanded access to multiple sclerosis teleneurology care following the COVID-19 pandemic
MP McGinley, S Gales, W Rowles… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Background Teleneurology for multiple sclerosis (MS) care was considered feasible, but
utilization was limited. Objective To describe how the existing teleneurology populations at …
utilization was limited. Objective To describe how the existing teleneurology populations at …
[HTML][HTML] Multiple sclerosis performance test (MSPT): normative study of 428 healthy participants ages 18 to 89
Abstract Background The Multiple Sclerosis Performance Test (MSPT) is a self-
administered, iPad®-based, computerized system for quantifying neuroperformance …
administered, iPad®-based, computerized system for quantifying neuroperformance …
[HTML][HTML] From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment
MF Raghib, E Bernitsas - Biomedicines, 2023 - mdpi.com
Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central
nervous system (CNS). Microbes, including bacteria and certain viruses, particularly Epstein …
nervous system (CNS). Microbes, including bacteria and certain viruses, particularly Epstein …
The immersive cleveland clinic virtual reality shopping platform for the assessment of instrumental activities of daily living
JL Alberts, M McGrath, MM Koop, C Waltz… - JoVE (Journal of …, 2022 - jove.com
A decline in the performance of instrumental activities of daily living (IADLs) has been
proposed as a prodromal marker of neurological disease. Existing clinical and performance …
proposed as a prodromal marker of neurological disease. Existing clinical and performance …